Objective-We demonstrated that inflammatory cells and intima-media thickening are increased in carotids exposed to lowblood flow in the SJL/J (SJL) strain compared with other mouse strains. We hypothesized that the extent of inflammation associated with intima-media thickening is a genetically regulated trait. Approach and Results-We performed a whole genome approach to measure leukocyte infiltration in the carotid intima as a quantitative trait in a genetic cross between C3HeB/FeJ (C3H/F) and SJL mice. Immunostaining for CD45 + (a pan-specific leukocyte marker) was performed on carotids from C3H/F, SJL, F1, and N2 progeny to measure leukocyte infiltration. We identified a nearly significant quantitative trait locus for CD45 + on chromosome (chr) 11 (17 cM, LOD=2.3; significance was considered at threshold P=0.05). Interval mapping showed that the CD45 + locus on chr 11 accounted for 8% of the variation in the logarithm of odds backcross. Importantly, the CD45 + locus colocalized with the intima-modifier 2 (Im2) locus, which controls 17% of intima variation. We created 2 Im2 congenic lines of mice (C3H/F.SJL.11.1 and C3H/F.SJL.11.2) to better understand the regulation of intima-media thickening by the chr 11 locus. The C3H/F.SJL.11.1 congenic mouse showed ≈30% of the SJL trait, confirming that CD45 + cell infiltration contributed to the intima trait. Conclusions-We discovered a novel locus on chr 11 that controls leukocyte infiltration in the carotid. Importantly, this locus overlaps with our previously published Im2 locus on chr 11. Our study reveals a potential mechanistic relationship between leukocyte infiltration and intima-media thickening in response to decreased blood flow. 
I n response to variations in hemodynamic parameters, the vessel wall remodels to compensate for changes in blood flow. [1] [2] [3] [4] An important clinical measurement of vascular remodeling is carotid intima-media thickening (IMT), which is associated with increased cardiovascular risks, such as stroke, myocardial infarction, and peripheral vascular disease. 5 Carotid IMT is a complex trait determined by genetic factors. Individuals with functional variations in genes associated with matrix deposition, inflammation, and lipid metabolism have a greater risk for carotid IMT. 6 Genetic linkage analyses have provided insight into genes that regulate IMT. [7] [8] [9] In the Framingham Heart Study, a quantitative trait locus (QTL) was identified for internal carotid IMT on human chromosome (chr) 12 (LOD=3.4). 9 More recently, Wang et al reported QTLs for IMT in a study of Dominican families on chrs 7 and 14, which house a primary gene candidate, proline-rich membrane anchor 1. 8 Genetic studies of IMT in animals have also been reported. 10, 11 Our group published a cross of C3HeB/FeJ (C3H/F) and SJL/J (SJL) (C3H/FxSJL) mice that identified 3 intima-modifier (Im) QTLs in response to decreased blood flow on chrs 2, 11, and 18 termed Im1, Im2, and Im3, respectively. 11 There are reported differences in immune response to various inflammatory stimuli between C3H/F and SJL mice. [12] [13] [14] [15] We have shown that in response to low-blood flow SJL mice develop significantly greater IMT accompanied by increased leukocyte infiltration in comparison with C3H/HeJ, C3H/F, and FVB/NJ mice. 12 This suggests there is genetic regulation of IMT that is partially driven by inflammation. In the current study, we used our previously characterized C3H/FxSJL cross to better understand the genetic regulation of inflammatory cell infiltration during vascular remodeling. Our goal was to identify a genomic locus which houses candidate genes that affect the inflammatory response during carotid IMT in response to low flow.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Quantitative CD45
+ and α 1 -Actin +
Immunostaining in C3H/FxSJL N2 Progeny
We reported that in response to decreased blood flow there was an increase in CD45 + cells in the intima of SJL relative to C3H/F. 12 In agreement with these previous findings, immunohistochemistry on carotid sections from the C3H/FxSJL cross demonstrated that infiltration of CD45 + cells in SJL was significantly greater compared with C3H/F ( Figure 1A and 1B) . In the N2 population, there was an intermediate phenotype for CD45 + cell infiltration ( Figure 1B ). The CD45 + distribution in the parentals and N2 strikingly resembled the distribution of IMT. 11 When normalized to smooth muscle α 1 -actin + , we found that the ratio of CD45 + expression to α 1 -actin + mirrored the relative staining of CD45 + alone (compare Figure 1B with Figure I in the online-only Data Supplement). Therefore, α 1 -actin + expression did not significantly affect the CD45 + trait. These results indicate that leukocyte infiltration contributes to IMT in SJL mice and the N2 progeny from the C3H/FxSJL cross.
QTL Analysis of CD45 + Expression
We performed QTL analysis for the CD45 + staining in the N2 progeny. We found a nearly significant locus on chr 11 (LOD=2.3; significance was considered at threshold P=0.05) and a second suggestive one on chr 9 (LOD=1.5; suggestive was considered at threshold P=0.67; Table and Figure 2A ). Interval mapping showed a peak of the locus on chr 11 at marker D11Mit231.1 ( Figure 2B ). Importantly, the CD45 + locus and its peak directly coincide with our previously reported Im2 peak on chr 11 for IMT 11 ( Figure 2B ). Figure 2 . Quantitative trait linkage analysis for CD45 + expression. A, All N2 progeny were used for quantitative trait locus (QTL) analysis of CD45 + expression. A, A nearly significant QTL was found on chromosome (chr) 11 (LOD 2.4) (arrow). A nearly suggestive QTL was identified on chr 9 (LOD 1.3). B, The QTL on chr 11 for CD45 + expression (dotted line) mapped to the same locus as the previously identified intima QTL (Im2) (black line). The peak of both QTLs was at marker D11Mit231. 1. suggesting that leukocyte infiltration and the intima trait are both regulated by the Im2 locus.
IMT in Im2 Congenic Mice
Because there was clear overlap of the CD45 + locus with the Im2 locus, we created congenic mice to study the regulation of IMT by the locus. We introgressed the Im2 chr 11 locus from SJL onto the C3H/F background using marker-assisted genotyping and created 2 congenic lines: C3H/F.SJL.11.1 and C3H/F.SJL.11.2 ( Figure 3A) . Both lines contain the entire Im2 locus, but C3H/F.SJL.11.2 contains additional SJL genomic material proximal to the peak locus marker (D11Mit231.1) ( Figure 3A ). We performed partial carotid ligation to create a low-flow environment on these congenic mice and quantified vessel wall compartment volumes to determine the contribution of the Im2 and CD45 + loci to IMT (Figure 3B-3E ; Figure  IIIA -IIIC in the online-only Data Supplement). Consistent with our previous findings, 11, 16 there was a significant increase in intima volume and intima/media ratio in SJL compared with all strains (Figure 3B and 3C) . The intima phenotype of the congenics was the same compared with the C3H/F background ( Figure 3B ). The same observation was found for media or adventitia volume in congenics compared with C3H/F ( Figure 3D and 3E) . We observed that SJL had significant decreases in lumen ( Figure IIIA in the online-only Data Supplement) and adventitia volume ( Figure 3E ) compared with C3H/F and congenic lines. There were no significant differences in intima+media or external elastic lamina between the parental and congenic mice ( Figure IIIB and IIIC in the online-only Data Supplement).
CD45 + Cell Infiltration in Im2 Congenic Mice
We did not observe an increase in intima volume along the length of the carotids in the congenic mice. cell infiltration in the C3H/F.SJL.11.1 mice was ≈30% of that measured in sections that displayed intima in SJL mice ( Figure  4A and 4B). CD45 + cell infiltration occurred more frequently in the intima of C3H/F.SJL.11.1 compared with the C3H/F. SJL.11.2 mice ( Figure 4A 
Discussion
The main finding of this study is the identification of a novel locus on chr 11 for CD45 + cell infiltration induced by lowblood flow. This locus maps to the same genomic location as our previously published intima-modifier, Im2, locus in the C3H/FxSJL backcross. In the present study, we generated congenic mice that express the Im2 locus from the SJL mice on the C3H/F background. The congenic mice revealed 2 important findings regarding the association between inflammation and IMT in response to low-blood flow: (1) Intima formation in the congenic mice was comparable with C3H/F mice, suggesting that the C3H/F genome functions to protect the vascular wall from intima formation. (2) Because CD45 + staining was observed in areas of the congenic mice, where the vessel wall had remodeled, we conclude that leukocyte infiltration only partially explains the intima trait. Thus, the Im2 and CD45 + loci play a role in recruiting or retaining inflammatory cells during vascular remodeling.
Carotid IMT in response to injury or altered blood flow is a complex multifactorial trait. The contribution of specific cell types to IMT remains to be defined. It is well accepted that vascular smooth muscle cell migration and proliferation are the major sources for IMT in response to multiple stimuli, including low-blood flow. 17, 18 However, circulating inflammatory cells and bone marrow-derived progenitor cells have also been shown to play a role in IMT. 19, 20 Other factors that need to be considered when determining mediators of IMT include the disease model, time course of cell infiltration, and strain background (hence genetic factors). We have shown that the C3H/F and SJL mice strains have significant differences in vascular remodeling in response to altered blood flow. 11, 16 Our interest was to determine whether there was genetic regulation of inflammation associated with IMT. Our current study presents evidence that leukocyte infiltration occurs in IMT, and that it is a genetically regulated trait.
We used our previously published C3H/FxSJL cross 11 to measure leukocyte infiltration and map loci that explain this trait. We found overlap on chr 11 for the CD45 + locus with our reported Im2 locus. We created 2 congenic mouse lines that carry SJL genomic information on the C3H/F background to further study the Im2 locus. The intima phenotype in both congenic lines was comparable with the parental C3H/F mice. This indicates that the C3H/F genome is dominant in regulating IMT. However, the genomic locus on chr 11 from SJL mice was able to promote a measurable amount of leukocyte infiltration, as indicated by the increased CD45 + cell infiltration in the C3H/F.SJL.11.1 congenic line. These findings support a genetic regulation of leukocyte infiltration in carotid IMT. Our data are consistent with a recent study by Orozco et al, which demonstrated using system genetics that inflammatory traits are highly influenced by genetic determinants. 21 The use of our congenic mice also emphasizes the importance of genetic regulation of complex traits, such as IMT. Although the Im2 congenic lines did not display a large intima phenotype, the C3H/F.SJL.11.1 did exhibit increased inflammation. Similar to a genome-wide association study of inflammation in coronary artery disease where chrs 6, 9, and 10 were shown to house both protective and promoting inflammatory genes, 22 our congenic mice presumably express both intima protective and promoting genes. Therefore, we conclude that the C3H/F genome is more dominant in protecting against IMT, whereas the SJL locus promotes inflammation and intima.
The overlapping Im2 and CD45 + loci suggest that this genomic region houses causal genes that promote IMT. Using the JaxLab phenome and single nucleotide polymorphism variation database (http://phenome.jax.org/db/q?rtn=docs/ genonav), we generated a list of ≈140 genes with single nucleotide polymorphisms differing between C3H/F and SJL mice in the region of the CD45 + locus (17-63 Mb) ( Table I in the online-only Data Supplement; bold font). We observed that 2 genes on the list were also identified in our previously published microarray data: epidermal growth factor-containing fibulin-like extracellular matrix 1 (Efemp1) and polyribonucleotide nucleotidyltransferase 1 (Pnpt1). 15 In an expression QTL (eQTL) analysis of macrophages from C3H/F mice, Pnpt1 expression was significantly increased relative to other strains (http://systems.genetics.ucla.edu/ data). 21 A future direction from this study will be to explore the potential role of macrophage Pnpt1 expression, as well as Efemp1, and its interaction with other inflammatory genes in IMT. IMT is an index of atherosclerosis, which is influenced by inflammation. Recently, a high-resolution genome-wide association analysis of aortic atherosclerosis loci in 22 different mouse strains, including a C3H substrain and SJL, identified genes on chr 1 that influence intima and vascular smooth muscle cell function. 23 Specifically, desmin (Des) was differentially expressed during atherogenesis. It would be interesting to see whether Des interacts with the Im2 locus to influence flow-induced vascular remodeling.
We did observe an increase in inflammation in the C3H/F. SJL.11.1 congenic mice, despite not having a large intima formation. We interpret this to mean that inflammation is not the primary cause of the intima trait, and that, by itself, the CD45 + locus within the Im2 locus only partially explains the entire IMT phenotype. In fact, we reported that the Im2 locus only accounts for 17% of the trait, 11 and it appears that the CD45 + trait contributes to ≈8% of that. Therefore, we speculate that genes in the Im2 locus are responsible for the immune response, whereas genes in the Im1 locus on chr 2 and Im3 locus on chr 18 work in trans to promote IMT. Therefore, a future direction of this study would be to determine the relationship of the CD45 + locus with the Im1 and Im3 loci. If the Im2 locus works to promote inflammation during vascular remodeling, then it is probable that the Im1 and Im3 loci function to promote vascular smooth muscle cell growth and migration as well as endothelial cell signaling. We have phenotypic evidence of IMT in our Im1 mice (data not shown). Therefore, investigating the candidate genes in the Im1 should provide further insight into interaction and regulation of inflammatory and growth genes across these loci.
Our data strongly indicate that the CD45 + locus houses genes that regulate inflammation in response to decreased blood flow. We recognize, however, that there is a limitation to our study. As discussed above, we are not certain whether the Im2 locus controls an early inflammatory response or contributes to a sustained immune response. We have only measured CD45 + staining 2 weeks post ligation. Thus, it is possible that CD45 + cell infiltration varied and possibly peaked at an earlier time point such as 1 week after low blood, as was reported in FVB/NJ mice for CD45 + cell count in the vascular wall. 24 Similarly, a study in apolipoprotein E knockout mice demonstrated that leukocyte infiltration peaked 1 week after injury. 25 Although we did not measure CD45 + cell infiltration at earlier time points, we can conclude that after 2 weeks of decreased blood flow there appears to be a sustained immune response in SJL and C3H/F.SJL.11.1 congenic mice, as we previously observed for SJL mice. 12 Therefore, our data indicate that inflammation is a part of vascular remodeling and that the CD45 + locus, which overlaps with the Im2 locus, partially explains prolonged inflammation associated with IMT.
In summary, we have identified a novel locus for leukocytemediated IMT. Genes within this locus likely contribute to the immune response in vascular remodeling and may provide insight into the treatment of inflammation associated with carotid IMT.
